Page last updated: 2024-08-24

ranolazine and Muscular Dystrophy, Animal

ranolazine has been researched along with Muscular Dystrophy, Animal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, PD; Altamirano, F; Burr, AR; Collins, J; Goonasekera, SA; López, JR; Ma, J; Millay, DP; Molkentin, JD; Park, KH; Philipson, KD; Sargent, MA	1

Other Studies

1 other study(ies) available for ranolazine and Muscular Dystrophy, Animal

Article	Year
Na+ dysregulation coupled with Ca2+ entry through NCX1 promotes muscular dystrophy in mice. Molecular and cellular biology, 2014, Volume: 34, Issue:11 Topics: Acetanilides; Animals; Calcium; Digoxin; Dysferlin; Enzyme Inhibitors; Hindlimb; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Knockout; Muscle, Skeletal; Muscular Dystrophy, Animal; Piperazines; Ranolazine; Sarcoglycans; Sodium; Sodium Channel Blockers; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase	2014

Article

Year

Na+ dysregulation coupled with Ca2+ entry through NCX1 promotes muscular dystrophy in mice.

Molecular and cellular biology, 2014, Volume: 34, Issue:11

Topics: Acetanilides; Animals; Calcium; Digoxin; Dysferlin; Enzyme Inhibitors; Hindlimb; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Knockout; Muscle, Skeletal; Muscular Dystrophy, Animal; Piperazines; Ranolazine; Sarcoglycans; Sodium; Sodium Channel Blockers; Sodium-Calcium Exchanger; Sodium-Potassium-Exchanging ATPase

2014